Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Rajeev Nannapaneni
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedYear |
1981
|
| gptkbp:founder |
V.C. Nannapaneni
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Natco Pharma Hyderabad
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
generic version of Lenalidomide
generic version of Sorafenib generic version of Tamiflu |
| gptkbp:numberOfEmployees |
over 5000
|
| gptkbp:products |
generic drugs
active pharmaceutical ingredients |
| gptkbp:servesArea |
worldwide
|
| gptkbp:specialty |
cardiology
oncology gastroenterology CNS (central nervous system) |
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:website |
https://www.natcopharma.co.in/
|
| gptkbp:bfsParent |
gptkb:Madhapur,_Hyderabad
|
| gptkbp:bfsLayer |
7
|